Abbott Seeks Expanded Labeling For CardioMEMS HF Monitor Based On GUIDE HF Results

The GUIDE HF investigators contend the trial missed its primary endpoint because of COVID-19.

• Source: Abbott

More from Clinical Trials

More from R&D